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SUMMARY
Objectives
In recent years, and especially in the past few months, the number of synthetic cannabinoid 
(bonsai) users has increased in our country. The aim of this study was to draw attention to the 
consumption of bonsai among young people and reveal the demographic and basic clinical 
characteristics of these users.
Methods
This was a retrospective study conducted at the Ümraniye Training and Research Hospital. All of 
the adult patients (≥18 year old) with synthetic cannabinoid intoxication who presented to the 
Emergency Department throughout the two years of the study (July 1st 2012–June 30th 2014) 
were enrolled. The frequencies were given as the median and inter-quartile range).
Results
197 patients were included in this study, with 190 male patients (96.4%) and 7 (3.6%) female 
patients. Two of the four hospitalized patients were exitus, 52 left on their own will and a total of 
141 patients were discharged after 6-12 hours of observation in the ED.
Conclusions
The use of synthetic cannabinoids (bonsai) in the recent years, especially in the summer months 
of 2014 was investigated in this study. Although these patients can have a benign clinical course, 
the process can also be fatal. It should especially be noted that patients with depressed respira-
tion, low GCs scores and high PaCO2 values are at higher risk for mortality and the necessity of 
early intubation should be kept in mind.
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Introduction
synthetic cannabinoids (sC) first emerged in 2004 and be-
came rapidly popular, especially among adolescents.[1,2] sC’s 
have various names worldwide, with the most common one 
being “spice”. However, in Turkey they are commonly known 
as “bonsai”.[3]
In recent years, especially in the last months, the number of 
bonsai users has increased in our country. 
In this study we aim to draw attention to the consumption 
of bonsai among young people and reveal the demographic 
and basic clinical characteristics of these users. This study 
was the sole study, which mentions the role of synthetic can-
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nabinoids as a public health problem in Turkey.
Materials and Methods
This was a retrospective descriptive cross-sectional study 
conducted at Ümraniye Training and Research Hospital. All 
of the adult patients who were over 17 years old with syn-
thetic cannabinoid intoxication and presented to the Emer-
gency Department (ED) throughout two years of the study 
(July 1st 2012–June 30th 2014) were enrolled. Patient records 
were obtained through the hospital information system 
(HIs). ICD codes F12.2, Z72.2, T40 and X44 were searched and 
charts that presented with “bonsai intoxication” were includ-
ed. Other drug intoxications and patients less than 18 years 
old were excluded from the study. suspicious abuse, patient 
data that was lacking and patients with a history of trauma 
were also excluded from the study. For the statistical analysis, 
sPss for Windows ver. 11.0 (Chicago, Il, UsA) was used. The 
frequencies were given as median and inter-quartile range. 
Results
There were 197 patients who were included in this study; 
190 patients (96.4%) were male and 7 (3.6%) were female. 
Two of hospitalized 4 patients (all were intubated) died, 52 
left refusing treatment, and a total of 141 patients were dis-
charged after 6–12 hours of observation in the ED. Patients’ 
median systolic blood pressure (sBP) sBP was 120 mmHg, 
diastolic blood pressure (DBP) was 70 mmHg and pulse rate 
was 89 beats/min. Median sBP of the four patients who were 
intubated was 110 mmHg, DBP was 69 mmHg and pulse rate 
was 71 beats/min. Demographic specifications of the pa-
tients and clinical characters are shown in Tables 1–3. During 
this two-year study the number of abuses rose significantly 
in the second year, especially in June 2014 as shown in Fig-
ures 1 and 2.
Discussion
Cannabinoids are separated into three main groups: en-
dogen, natural and synthetic. sC’s were natural-synthetic 
mixtures sold as legalized marijuana in some countries and 
smoked in the form of cigarettes.[3] The most common form 
of natural cannabinoid is 9-tetrahydrocannabinol (THC).[3,4] 
Cannabinoids affect the CB1 and CB2 receptors in the body 
and they show these effects generally based on a CB1 like 
mechanism of action, impaired consciousness, sleep chang-
es and cardiovascular effects. Whereas the role of CB2 is 
poorly understood, it is known that THC acts only through 
CB1. This is different than sC’s, which act both through the 
CB1 and CB2 receptors and are more effective than THC.[5–7]
The popularity of these drugs is growing since they cannot 
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Table 1. Demographical findings and vital signs of all 
of the patients
Variable Median (IQR)
Age (year) 22 (19-27)
Male (n, %) 190 (96.4) 
Pulse (beats/min) 89 (78-105)
sBP (mmHg) 120 (110-126)
DBP (mmHg) 70 (62-80)
saO2 (%-%) 98 (97-99)
GCs  15 (15-15)
IQR: Inter quartile range; sBP: systolic blood pressure; DBP: Diastolic blood 
pressure; saO2: saturation of oxygen; GCs: Glasgow coma scale score.
Table 2. Demographical findings and vital signs of the 
patients who were intubated
Variable Median (IQR)
Age (year) 29 (23-24)
Male (n, %) 4 (100.0)
Pulse (beats/min) 71 (45-125)
sBP (mmHg) 110 (83-125)
DBP (mmHg) 68 (45-77)
saO2 (%-%) 41 (15-41)
GCs  3 (3-4)
IQR: Inter quartile range; sBP: systolic blood pressure; DBP: Diastolic blood 
pressure; saO2: saturation of oxygen; GCs: Glasgow coma scale score.
Table 3. Outcomes of intubated patients and their blood gas results
Patient Age/sex Clinical result pH pO2 (mmHg) PCO2 (mmHg) HCO3 (mmHg)
Patient 1 34/male Intubated+Exitus 6.91 15 128 12
Patient 2 26/male Intubated+Exitus 6.58 65 173 ?
Patient 3 19/male Intubated+Discharged 7.06 42 61 14
Patient 4 24/male Intubated+Discharged 6.90 40 119 11
be detected with routine screening tests and they are cheap 
and especially appealing to young people. In our study the 
median age was 22 years and there was a male gender pre-
dominance. These results were similar to the results of previ-
ous studies. Hoyte et al found the median age as 22.5 years 
and with a male gender predominance, although this was 
slightly lower than our results (cases reported in males was 
74.3%).[1] Though it remains undetected through routine 
screening, they can be detected with new immunoassay 
methods and research is ongoing in this field.[8] Psychoactive 
effects of the sC’s are similar to the effects of THC, but they 
are more potent. These drugs can cause anxiety or panic as 
well as opposing effects like repressed anxiety. The most fre-
quent cardiovascular effects are hypertension and tachycar-
dia, but effects such as bradycardia and hypotension have 
also been reported.[4,9]
In our study, patients’ median sBP was 120 mmHg, DBP was 
70 mmHg and pulse rate 89/min, and these values were con-
sidered the normal range. Although 4 intubated patients 
had pulse rates and blood pressures (BP) that were slightly 
lower with respect to all other patients pulse rates and BPs, 
they were still in the normal range. However, in our study the 
patients GCs was an average of 15 and there was no obvi-
ous hypoxia, with the sO2 average of the intubated patients 
measured as low as 41%. These patients had 3-4 GCs scores 
and their high PaCO2 in the blood gas was noteworthy. These 
four patients were intubated due to their low GCs scores, low 
PaO2, and high paCO2 levels although they had normal pulse 
rates and normal BPs. The respiratory suppression state of 
these patients was thought to have gotten worse due to sec-
ondary hypercapnia, respiratory and metabolic acidosis. The 
death of 2 of the 4 intubated patients doesn’t mean that the 
cannabinoids are harmless, but rather it can be seen as evi-
dence that may change widely accepted assumptions about 
the safety of these drugs. Deaths caused by cannabinoids 
were not expected but that the fact that the sC’s have a wide 
clinical spectrum from benign to death is quite remarkable. 
In recent months, especially in June 2014, the high patient 
admission rate is conspicuous. Again in these months the 
use of bonsai and the bonsai related deaths frequently an-
nounced in the media has increased public awareness. The 
answer of why patient numbers increased so dramatically 
in the last month is unclear but according to police officers’ 
declarations, the usage of bonsai rises each day. The Turk-
ish Monitoring Centre for Drugs and Drug Addiction 2013 
report results revealed that the number of people that used 
sCs were 20 times higher in 2012 than in 2011. The report 
for 2014 has not been published yet but we think that sC 
consumption rose much more this year than in the previous 
years.[10] 
Conclusion
The use of synthetic cannabinoids (bonsai) in the recent 
years, especially in the summer months of 2014 is stated 
in this paper. Although patients can have a benign clini-
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Figure 1. Number of patients presented to ED with bonsai consumption according to months.
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Figure 2. Number of patients presented to ED with bonsai con-
sumption according to years.
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cal course, the process can also be fatal. It should be noted 
that especially patients with depressed respiration, low GCs 
scores and high PaCO2 values are at increased risk and the 
necessity of early intubation should be kept in mind.
Limitations
The major limitation of the study was its retrospective na-
ture. The second limitation was the absence of screening 
tests for the synthetic cannabinoid. Confirmation of bon-
sai consumption was based on the medical history learned 
from the patients or their relatives. However, it is known that 
detection of these substances with routine screening tests 
is not possible in most medical care centers in Turkey, so an-
amnesis was the only method for confirmation.
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